Analysis of glomerulopathies in kidney neoplasms

Background. Malignant neoplasms, including those of the kidneys, are widespread in the world. The main treatment for kidney tumors is surgery, one of its options is nephrectomy. Malignant tumors of various localizations can lead to a variety of kidney damage. Glomerulopathies of various origins are often asymptomatic, and therefore, patients do not seek medical help. For the diagnosis of glomerulopathies, it is necessary to assess morphological changes with the formulation of an immunofluorescence reaction and electron microscopy.

The aim: to analyze the clinical manifestations, frequency and structure of glomerulopathies in kidney neoplasms.

Patients and Methods. The study included 141 patients. The patients underwent nephrectomy, the daily protein loss, the number of altered erythrocytes in the urine, the level of creatinine in the blood serum were determined, and the glomerular filtration rate (CKD-EPI) was calculated. Morphological evaluation of samples included immunofluorescence reaction and electron microscopy. To assess the statistical significance of the relationship between variables, Spearman's nonparametric rank correlation coefficient (Rs) was calculated. The results obtained were considered significant at p<0.05. RESULTS. Glomerulopathies were detected in 41.8 % of patients. Glomerulonephritis was observed in 10.6 % of cases and diabetic nephropathy was detected in 31.2 % of patients. Prior to nephrectomy, proteinuria was higher in patients with glomerulonephritis; after surgical treatment, there were no differences in the level of proteinuria. Before nephrectomy, there were no significant differences in glomerular filtration rate; after surgery, glomerular filtration rate was higher in patients without glomerular pathology. After one year, there was a significant decrease in glomerular filtration rate in patients with glomerulopathies. CONCLUSION. When examining the surgical material, the morphologist should also evaluate changes in the kidney tissue outside the tumor. It is advisable to jointly manage the patient by an oncologist and a nephrologist Keywords: tumor, glomerulonephritis, diabetic nephropathy, glomerular filtration rate> ˂ 0.05.

Results. Glomerulopathies were detected in 41.8 % of patients. Glomerulonephritis was observed in 10.6 % of cases and diabetic nephropathy was detected in 31.2 % of patients. Prior to nephrectomy, proteinuria was higher in patients with glomerulonephritis; after surgical treatment, there were no differences in the level of proteinuria. Before nephrectomy, there were no significant differences in glomerular filtration rate; after surgery, glomerular filtration rate was higher in patients without glomerular pathology. After one year, there was a significant decrease in glomerular filtration rate in patients with glomerulopathies.

Conclusion. When examining the surgical material, the morphologist should also evaluate changes in the kidney tissue outside the tumor. It is advisable to jointly manage the patient by an oncologist and a nephrologist.

1. Amin MB, Berney DM, Comperat EM, Hartmann A, Menon S, Netto GJ et al. (eds.). WHO classification of tumours. Urinary and male genital tumours. V. 8 5th ed. Lyon: IARC, 2022 576 p

2. Ministry of Health of the Russian Federation. Clinical guidelines. Cancer of the parenchyma of the kidney. M., 2021;102 p

3. Kolina IB, Bobkova IN. Nephropathies in malignant tumors (lecture). Almanac Of Clinical Medicine 2014;30:108-116. (In Russ.)

4. Wei YF, Chen JY, Lee HS, Wu JT, Hsu CK, Hsu YC. Association of chronic kidney disease with mortality risk in patients with lung cancer: a nationwide Taiwan population-based cohort study. BMJ Open 2018;24(8):1-6. doi: 10.1136/bmjopen-2017-019661

5. Dzhumabaeva BT, Biryukova LS. New aspects of pathophysiology and pathomorphology of renal lesions in malignant tumors. Klinical Onkogematol 2015;8(4):390-396. (In Russ.)

6. Fried LF, Katz R, Sarnak MJ, Shlipak MG, Chaves PH, Jenny NS, Stehman-Breen C, Gillen D, Bleyer AJ, Hirsch C, Siscovick D, Newman AB. Kidney function as a predictor of noncardiovascular mortality. Journal the American Society of Nephrology 2005;16(12):3728-3735. doi: 10.1681/ASN.2005040384

7. Garkusha TA, Stolyarevich ES, Khorzhevsky VA, Ivliev SV. Glomerulopathy in kidney neoglasms: frequency of occurrence, structure of morbidity. Arkhiv Pathologii 2023;85(2):21-26 (In Russ.) doi: 10.17116/patol20238502121

8. Tojo A. Paraneoplastic glomerulopathy associated with renal cell carcinoma. In: J Chen (ed.). Renal Tumor. London: IntechOpen; 2013. P. 109-130. doi: 10.5772/53534

9. Pani A, Porta C, Cosmai L, Melis P, Floris M, Piras D, Gallieni M, Rosner M, Ponticelli C. Glomerular diseases and cancer: evaluation of underlying malignancy. Journal Nephrology 2016;29(2):143-152. doi: 10.1007/s40620-015-0234-9

10. Song F, Liu C, Zhang J, Hu Z. Renal cell carcinoma with nephrotic syndrome: a case report and literature review. Translationai Andrology and Urolgy 2020;9(3):1459-1465. doi: 10.21037/tau.2020.03.41

11. Garkusha TA, Bykhanova EA, Khorzhevskii VA, Gappoev SV, Firsov MA, Ivliev SV. The incidence of glomerulopathies in kidney neoplasms in Krasnoyarsk. Clinical and experimental morphology 2022;11(3):15-21 (In Russ.). doi: 10.31088/CEM2022.11.3.15-21

12. RB Colvin, A Chang. Diagnostic Pathology: Kidney Diseases. 2nd ed. Philadelphia; Elsevier; 2016: 48-668

13. Jhaveri KD, Shah HH, Calderon K, Campenot ES, Radhakrishnan J. Glomerular diseases seen with cancer and chemotherapy: a narrative review. Kidney International 2013;84(1):34-44. doi: 10.1038/ki.2012.484

14. Jhaveri KD, Shah HH, Patel C, Kadiyala A, Stokes MB, Radhakrishnan J. Glomerular diseases associated with cancer, chemotherapy, and hematopoietic stem cell transplantation. Advances in Chronic Kidney Disease 2014;21(1):48-55. doi: 10.1053/j.ackd.2013.08.003

15. Jhaveri KD, Shah HH, Calderon K, Campenot ES, Radhakrishnan J. Glomerular diseases seen with cancer and chemotherapy: a narrative review. Kidney International 2013;84(1):34-44. doi: 10.1038/ki.2012.484

16. Kim SH, Park SJ, Han KH, Kronbichler A, Saleem MA, Oh J, Lim BJ, Shin JI. Pathogenesis of minimal change nephrotic syndrome: an immunological concept. Korean Journal of Pediatrics 2016;59(5):205-211. doi: 10.3345/kjp.2016.59.5.205

17. Bacchetta J, Juillard L, Cochat P, Droz JP. Paraneoplastic glomerular diseases and malignancies. Critical Reviews in Oncology/Hematology 2009;70(1):39-58. doi: 10.1016/j.critrevonc.2008.08.003

18. Alchi B, Jayne D. Membranoproliferative glomerulonephritis. Pediatric Nephrology 2010;25(8):1409-1418. doi: 10.1007/s00467-009-1322-7

19. Rosner MH, Jhaveri KD, McMahon BA, Perazella MA. Onconephrology: The intersections between the kidney and cancer. CA Cancer J Clin 2021 Jan;71(1):47-77. doi: 10.3322/caac.21636